Table 5.
Quartile | Propensity score range | Use of cACEi or cARB (no of participants) | ||
Yes | No | Total at baseline | ||
1 | 0.00–0.07 | 3 | 72 | 75 |
2 | 0.06–0.13 | 8 | 67 | 75 |
3 | 0.17–0.23 | 11 | 64 | 75 |
4 | 0.23–0.78 | 31 | 44 | 75 |
Total | 53 | 247 | 300 |
cACEi, centrally acting ACE inhibitor; cARB, centrally acting angiotensin receptor blocker.